Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06660940 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Trial of Keluoxin Capsules in the Treatment of Diabetic Kidney Disease with Diabetic Retinopathy

StatusNot Yet Recruiting
PhasePhase 4
Started2024-10
View on ClinicalTrials.gov ↗
The purpose of the study is to evaluate the efficacy of Keluoxin Capsules for the treatment of diabetic kidney disease (DKD) and diabetic retinopathy (DR) compared to placebo on a conventional treatment basis.
Trial Details
NCT Number NCT06660940
Lead Sponsor Chinese PLA General Hospital
Conditions Diabetic Kidney Disease, Diabetic Retinopathy
Enrollment 460 participants
Start Date 2024-10
Primary Completion 2027-10 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2024-10-28